Pediatrix Medical Group, Inc.
- Stock
- Ticker MD
- ISIN US58502B1061
- NYSE
Performance, volatility and drawdowns of Pediatrix Medical Group, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $4,679. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −90.6% in 06/2024, measured from the peak in 03/2017. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 502 | 458 | 469 | 493 | 494 | 476 | 488 | 501 |
| Operating income | 39 | 32 | 60 | 68 | 49 | 42 | 57 | 65 |
| EBITDA | 46 | 37 | 65 | 74 | 54 | 48 | 63 | 71 |
| Net income | 30 | 21 | 39 | 72 | 34 | 30 | 40 | 47 |
| Earnings per share | 0.37 | 0.24 | 0.46 | 0.84 | 0.40 | 0.36 | 0.49 | 0.59 |
| Balance sheet | ||||||||
| Total assets | 2,153 | 1,993 | 2,102 | 2,199 | 2,247 | 2,070 | 2,130 | 2,139 |
| Liabilities | 1,388 | 1,204 | 1,268 | 1,309 | 1,381 | 1,192 | 1,249 | 1,290 |
| Equity | 765 | 789 | 834 | 891 | 866 | 879 | 881 | 850 |
| Cash | 230 | 99 | 225 | 340 | 375 | 206 | 289 | 312 |
| Long-term debt | 611 | – | – | – | – | – | – | – |
| Cash flow | ||||||||
| Operating cash flow | 133 | -117 | 137 | 137 | 114 | -130 | 125 | 117 |
| Free cash flow | 133 | -117 | 137 | 137 | 114 | -130 | 125 | 117 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +63.0%, weakest 2022 at −45.4%. 3 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 29 Oct 2026 | $0.59 |
| 4 Aug 2026 | $0.49 |
| 5 May 2026 | $0.36 |
| 19 Feb 2026 | $0.40 |
| 3 Nov 2025 | $0.84 |
| 5 Aug 2025 | $0.46 |
| 6 May 2025 | $0.24 |
| 20 Feb 2025 | $0.37 |
| 1 Nov 2024 | $0.23 |
| 6 Aug 2024 | −$1.84 |
| 7 May 2024 | $0.05 |
| 20 Feb 2024 | −$1.50 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €2.1bn
- Market cap in trading currency
- $2.36bn
- Enterprise value
- $1.94bn
- P/E
- 16.4
- P/S
- 1.21
- P/B
- 2.78
- EV/Sales
- 0.99
- EV/EBITDA
- 8.2
- Earnings yield
- 6.1%
- FCF yield
- 9.6%
Results (last four quarters)
- Revenue
- $1.96bn
- Gross profit
- –
- EBITDA
- $236m
- Net income
- $150m
- Earnings per share
- $1.84
- Revenue per share
- $25.08
- Revenue growth
- +1.7%
- Earnings growth
- −34.5%
Profitability
- Gross margin
- –
- Operating margin
- 10.9%
- Net margin
- 7.7%
- Return on equity
- 17.2%
- Return on assets
- 7.0%
Balance sheet and cash flow
- Cash
- $426m
- Cash per share
- $5.45
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 1.28
- Book value per share
- $10.88
- Operating cash flow
- $227m
- Free cash flow
- $227m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 78.1m
- Volume
- 790,856
- Avg. volume 3 months
- 740,973
- Relative volume
- 1.1
Price and technicals
- Price
- $30.22
- 1 day
- +0.9%
- 52-week high
- $32.80
- 52-week low
- $18.82
- Distance to 52-week high
- −7.9%
- Distance to 52-week low
- +60.6%
- Distance to 50-day line
- +6.9%
- Distance to 200-day line
- +22.8%
- RSI (14)
- 52
- Volatility 1M
- 35.0%
Performance
- 1 week
- −3.5%
- 1 month
- +2.3%
- 3 months
- +13.6%
- 6 months
- +42.1%
- YTD
- +41.3%
- 1 year
- +31.8%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has MD performed since 11/2016?
$10,000 grew to $4,679 by 20 Nov 2026, which is −7.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is MD?
Volatility was 47.5% per year, measured on monthly returns. The largest decline from a peak was −90.6%, with the low in 06/2024.
How does MD compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, MD returned −7.3% at 47.5%. The correlation of monthly returns was 0.43; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.